Its $25M Series A in-hand, its healthcare- and tech-deep board, investors and management chart an ambitious path.
[Updated] Vanguard alumni aim to make high-quality cancer care more affordable, accessible, patient-centric.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: